Abstract FZJ-2021-04526

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Comparison of the novel α4β2 nicotinic acetylcholine receptor PET radioligands (-)-Flubatine and (+)-Flubatine in Healthy Controls

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2019

NuklearMedizin 2019, BremenBremen, Germany, 3 Apr 2019 - 6 Apr 20192019-04-032019-04-06 [10.1055/s-0039-1683635]

This record in other databases:

Please use a persistent id in citations: doi:

Abstract: Nuklearmedizin 2019; 58(02): 159-160.


Contributing Institute(s):
  1. Zentralinstitut für Elektronik (ZEA-2)
Research Program(s):
  1. 5253 - Neuroimaging (POF4-525) (POF4-525)
  2. NikotinPET - Validierung von (+)-[18F]Flubatine als PET-Radiotracer zur Untersuchung von Nikotinrezeptoren bei Demenz (HGF-HVF-0012) (HGF-HVF-0012)
  3. BMBF-01EZ0822 - NorChloro-Fluoro HomoEpiBatidin (NCFHEB) ein potentieller Positronen-Emission Tomographie-(PET) Marker der frühen Alzheimer-Demenz (BMBF-01EZ0822) (BMBF-01EZ0822)

Click to display QR Code for this record

The record appears in these collections:
Document types > Presentations > Abstracts
Institute Collections > ZEA > ZEA-2
Institute Collections > PGI > PGI-4
Workflow collections > Public records
Publications database

 Record created 2021-11-24, last modified 2025-01-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)